Part D Price Negotiations Still On Ways And Means Committee’s 2007 Agenda
Executive Summary
Even though the House passed legislation that would require HHS to engage in price negotiations for Medicare Part D drugs, price negotiations remain on the House Ways and Means Committee list of Part D-related issues the congressional body plans to examine during the 110th Congress